NCT01076218已完成不适用
In Clinic Evaluation of the FreeStyle Navigator® Continuous Glucose Monitoring System Version 1.5
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 57
- 试验地点
- 2
研究概览
简要总结
The purpose of the study is to confirm that the accuracy and safety of Version 1.5 of the FreeStyle Navigator Continuous Glucose Monitoring System are not impacted by the updates to the system algorithm and minor changes to the user interface and sensor delivery unit, such as adhesive sterilization method. It is anticipated that information collected will be submitted as a supplement to Premarket Approval Application (P050020) to the US Food and Drug Administration for approval to market this version of the system.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •History consistent with Type 1 diabetes for at least 2 years prior to enrollment;
- •For at least 6 months prior to enrollment, insulin pump user or multiple daily insulin injections;
- •At least 18 years of age;
- •Available and capable of following the protocol instructions provided by the healthcare professional;
- •Signed and dated Informed Consent form.
排除标准
- •Pregnancy;
- •Type 2, gestational, or secondary diabetes;
- •Known allergy to medical grade adhesives or skin disinfectant;
- •Skin abnormalities at the insertion sites that would confound the assessment of the effect of the device on the skin;
- •Blood donation within 6 weeks prior to beginning study activities;
- •Within past 6 months, severe hypoglycemic episode(s) resulting in hospitalization or loss of consciousness;
- •Active myocardial ischemia;
- •Previous history of stroke;
- •Any other concomitant medical condition that in the opinion of the principal investigator would likely affect the evaluation of device performance and/or safety;
- •Current participation in another clinical trial.
研究者
研究点 (2)
Loading locations...
相似试验
已完成
1 期
Safety of 4Fluart ID Suspension for Injection in Adult SubjectsHuman InfluenzaNCT03448705Fluart Innovative Vaccine Ltd, Hungary36
已完成
不适用
Clinical and Usability Study to Determine Safety and Efficacy of the Clear Device for Acne TreatmentMonitor Acne Lessions Count Reduction as Result of Usinfg the DeviceNCT01678482Home Skinovations Ltd.50
已完成
1 期
Safety, Tolerability and Preliminary Efficacy of FP-1201 in ALI and ARDS. Phase I/IIAcute Lung InjuryAcute Respiratory Distress SyndromeNCT00789685Faron Pharmaceuticals Ltd37
Unknown
2 期
Endostar + GT in Pulmonary Metastases of Soft Tissue SarcomaSoft Tissue SarcomaNCT01812018Peng Yuan30
进行中（未招募）
1 期
A Study of CFI-400945 With or Without Azacitidine in Patients With AML, MDS or CMMLMyelodysplastic SyndromesAcute Myeloid LeukemiaMDSAMLCMMLChronic Myelomonocytic LeukemiaNCT04730258Treadwell Therapeutics, Inc72